SMid Cap Biotech Analyst Romero, along with CEO Adams, CFO Schneyer and COO Teehan, hold a post 3Q24 reported earnings conference call on November 7 at 11:30 am. Webcast Link
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACAD:
- Acadia Pharmaceuticals Sees Revenue Growth and Strategic Advances
- Acadia Pharmaceuticals reports Q3 EPS , consensus 14c
- Acadia Pharmaceuticals sees FY24 revenue $940M-$960M, consensus $952.5M
- Acadia Pharma sells Rare Pediatric Disease Priority Review Voucher for $150M
- ACAD Upcoming Earnings Report: What to Expect?